Glucocorticoids and Skin Healing in Diabetes (GC-SHealD)
Status:
Completed
Trial end date:
2019-03-13
Target enrollment:
Participant gender:
Summary
The study aims to investigate effects of inhibiting glucocorticoid activation on skin
function and wound healing in patients with type 2 diabetes. Half of patients will be given a
drug to inhibit glucocorticoid activation and the other half will be given a placebo.